Next Article in Journal
Characterization of Two Historic Smallpox Specimens from a Czech Museum
Previous Article in Journal
Infectious Bronchitis Virus Infection Induces Apoptosis during Replication in Chicken Macrophage HD11 Cells
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

HBV Drug Resistance Substitutions Existed before the Clinical Approval of Nucleos(t)ide Analogues: A Bioinformatic Analysis by GenBank Data Mining

Department of Microbiology and Center of Infectious Disease, School of Basic Medical Sciences, Peking University Health Science Center, Beijing 100191, China
*
Authors to whom correspondence should be addressed.
Viruses 2017, 9(8), 199; https://doi.org/10.3390/v9080199
Submission received: 24 May 2017 / Revised: 21 July 2017 / Accepted: 24 July 2017 / Published: 27 July 2017
(This article belongs to the Section Viral Immunology, Vaccines, and Antivirals)

Abstract

Naturally occurring nucleos(t)ide analogue resistance (NUCr) substitution frequencies in the reverse transcriptase (RT) of the hepatitis B virus (HBV) were studied extensively after the clinical approval of nucleos(t)ide analogues (NUCs; year of approval 1998). We aimed to study NUCr substitutions in HBV RT sequences obtained before 1998 and better understand the evolution of RT sequences without NUC pressures. Our strategy was to retrieve HBV sequences from GenBank deposited before 1998. The initial search used the keywords “hepatitis B virus” or “HBV” and 1139 sequences were found. Data analyses included information extraction: sequence quality control and amino acid substitution analysis on 8 primary NUCr and 3 secondary substitution codons. Three hundred and ninety-four RT-containing sequences of 8 genotypes from 25 countries in 4 continents were selected. Twenty-seven (6.9%) sequences were found to harbor substitutions at NUCr-related codons. Secondary substitutions (rtL80V and rtV173G/A/L) occurred more frequently than primary NUCr substitutions (rtI169L; rtA181G; T184A/S; rtS202T/R; rtM204L and rtM250K). Typical amino acid substitutions associated with NUCr were of rtL80V, rtV173L and rtT184A/S. We confirm the presence of naturally occurring typical HBV NUCr substitutions with very low frequencies, and secondary substitutions are more likely to occur than primary NUCr substitutions without the selective pressure of NUCs.
Keywords: hepatitis B virus; reverse transcriptase; nucleos(t)ides analogue resistance; substitution; pre-existing; naturally occurring hepatitis B virus; reverse transcriptase; nucleos(t)ides analogue resistance; substitution; pre-existing; naturally occurring

Share and Cite

MDPI and ACS Style

Xu, X.; Xiang, K.; Su, M.; Li, Y.; Ji, W.; Li, Y.; Zhuang, H.; Li, T. HBV Drug Resistance Substitutions Existed before the Clinical Approval of Nucleos(t)ide Analogues: A Bioinformatic Analysis by GenBank Data Mining. Viruses 2017, 9, 199. https://doi.org/10.3390/v9080199

AMA Style

Xu X, Xiang K, Su M, Li Y, Ji W, Li Y, Zhuang H, Li T. HBV Drug Resistance Substitutions Existed before the Clinical Approval of Nucleos(t)ide Analogues: A Bioinformatic Analysis by GenBank Data Mining. Viruses. 2017; 9(8):199. https://doi.org/10.3390/v9080199

Chicago/Turabian Style

Xu, Xizhan, Kuanhui Xiang, Mingze Su, Yao Li, Wei Ji, Yutang Li, Hui Zhuang, and Tong Li. 2017. "HBV Drug Resistance Substitutions Existed before the Clinical Approval of Nucleos(t)ide Analogues: A Bioinformatic Analysis by GenBank Data Mining" Viruses 9, no. 8: 199. https://doi.org/10.3390/v9080199

APA Style

Xu, X., Xiang, K., Su, M., Li, Y., Ji, W., Li, Y., Zhuang, H., & Li, T. (2017). HBV Drug Resistance Substitutions Existed before the Clinical Approval of Nucleos(t)ide Analogues: A Bioinformatic Analysis by GenBank Data Mining. Viruses, 9(8), 199. https://doi.org/10.3390/v9080199

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop